Skip to content
Menu
  • PROJECT
    • CONCEPT
    • PROJECT AIMS
    • TECHNOLOGY
    • VACCINE STRATEGY
  • PEOPLE
    • COORDINATOR
    • PARTNERS
    • ADVISORY BOARDS
  • TARGETED DISEASES
    • SYNUCLEINOPATHIES
    • PARKINSON’S DISEASE
    • MULTIPLE SYSTEM ATROPHY
    • GLOSSARY
    • LINKS
  • EVENTS
    • SYMPOSIUM
    • PROJECT MEETINGS
    • SYMPATH – FAHR MIT
      • FAHR MIT – STAGES
    • VISIT TO VIENNA CITY HALL
    • PHOTO BOOK PRESENTATION
  • MEDIA CENTER
    • PROJECT INFORMATION
    • VIDEO
    • PHOTO BOOK
    • PUBLICATIONS
    • PRESS RELEASES
    • PRESS PHOTOS
  • CONTACT
    • LEGAL NOTICE
    • PRIVACY POLICY
Arrow
Arrow
Slider

THE SYMPATH PROJECT

SYMPATH is an EU funded research project to assess the safety of the first two therapeutic vaccine candidates for Parkinson´s disease and multiple-system atrophy. The final vision targets to develop a symptomatic effective and potentially disease modifying vaccine.

UNIVERSITY HOSPITAL BORDEAUX
INSERM F-CRIN TOULOUSE
UNIVERSITY HOSPITAL TOULOUSE
FORSCHUNGSZENTRUM JÜLICH
MEDICAL UNIVERSITY INNSBRUCK
AFFIRIS
BIOLUTION
PROSENEX


   
This project receives funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement: 602999

HON   
This site complies with the HONcode standard for trustworthy health information: verify here.
Copyright © 2021 biolution GmbH

By continuing to use the site, you agree to the use of cookies. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close